These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23284754)

  • 21. Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast.
    Bae JS; Choi JS; Baik SH; Park WC; Song BJ; Kim JS; Lim Y; Jung SS
    World J Surg Oncol; 2010 Apr; 8():32. PubMed ID: 20409316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues.
    Tsuji K; Kawauchi S; Saito S; Furuya T; Ikemoto K; Nakao M; Yamamoto S; Oka M; Hirano T; Sasaki K
    BMC Cancer; 2010 Jan; 10():15. PubMed ID: 20070913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.
    Chin SF; Teschendorff AE; Marioni JC; Wang Y; Barbosa-Morais NL; Thorne NP; Costa JL; Pinder SE; van de Wiel MA; Green AR; Ellis IO; Porter PL; Tavaré S; Brenton JD; Ylstra B; Caldas C
    Genome Biol; 2007; 8(10):R215. PubMed ID: 17925008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
    Kamradt J; Jung V; Wahrheit K; Tolosi L; Rahnenfuehrer J; Schilling M; Walker R; Davis S; Stoeckle M; Meltzer P; Wullich B
    PLoS One; 2007 Aug; 2(8):e769. PubMed ID: 17712417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the significance of conserved genomic aberrations using high resolution genomic microarrays.
    Guttman M; Mies C; Dudycz-Sulicz K; Diskin SJ; Baldwin DA; Stoeckert CJ; Grant GR
    PLoS Genet; 2007 Aug; 3(8):e143. PubMed ID: 17722985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
    Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
    Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.
    Natrajan R; Wilkerson PM; Marchiò C; Piscuoglio S; Ng CK; Wai P; Lambros MB; Samartzis EP; Dedes KJ; Frankum J; Bajrami I; Kopec A; Mackay A; A'hern R; Fenwick K; Kozarewa I; Hakas J; Mitsopoulos C; Hardisson D; Lord CJ; Kumar-Sinha C; Ashworth A; Weigelt B; Sapino A; Chinnaiyan AM; Maher CA; Reis-Filho JS
    J Pathol; 2014 Apr; 232(5):553-65. PubMed ID: 24395524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer.
    Kikuchi-Koike R; Nagasaka K; Tsuda H; Ishii Y; Sakamoto M; Kikuchi Y; Fukui S; Miyagawa Y; Hiraike H; Kobayashi T; Kinoshita T; Kanai Y; Shibata T; Imoto I; Inazawa J; Matsubara O; Ayabe T
    BMC Cancer; 2019 May; 19(1):521. PubMed ID: 31146704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
    Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
    Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.
    Holstege H; Horlings HM; Velds A; Langerød A; Børresen-Dale AL; van de Vijver MJ; Nederlof PM; Jonkers J
    BMC Cancer; 2010 Nov; 10():654. PubMed ID: 21118481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.
    Pinkel D; Segraves R; Sudar D; Clark S; Poole I; Kowbel D; Collins C; Kuo WL; Chen C; Zhai Y; Dairkee SH; Ljung BM; Gray JW; Albertson DG
    Nat Genet; 1998 Oct; 20(2):207-11. PubMed ID: 9771718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequency of common DNA copy number abnormalities detected by bacterial artificial chromosome array comparative genomic hybridization in 24 breast cancer cell lines.
    Saito S; Morita K; Hirano T
    Hum Cell; 2009 Feb; 22(1):1-10. PubMed ID: 19222606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA copy number aberrations in breast cancer by array comparative genomic hybridization.
    Li J; Wang K; Li S; Timmermans-Wielenga V; Rank F; Wiuf C; Zhang X; Yang H; Bolund L
    Genomics Proteomics Bioinformatics; 2009 Jun; 7(1-2):13-24. PubMed ID: 19591788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases.
    Vollebergh MA; Klijn C; Schouten PC; Wesseling J; Israeli D; Ylstra B; Wessels LF; Jonkers J; Linn SC
    PLoS One; 2014; 9(8):e103177. PubMed ID: 25083859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of genomic instability in breast cancer in atomic bomb survivors: analysis of microarray-comparative genomic hybridization.
    Oikawa M; Yoshiura K; Kondo H; Miura S; Nagayasu T; Nakashima M
    Radiat Oncol; 2011 Dec; 6():168. PubMed ID: 22152285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtypes of familial breast tumours revealed by expression and copy number profiling.
    Waddell N; Arnold J; Cocciardi S; da Silva L; Marsh A; Riley J; Johnstone CN; Orloff M; Assie G; Eng C; Reid L; Keith P; Yan M; Fox S; Devilee P; Godwin AK; Hogervorst FB; Couch F; ; Grimmond S; Flanagan JM; Khanna K; Simpson PT; Lakhani SR; Chenevix-Trench G
    Breast Cancer Res Treat; 2010 Oct; 123(3):661-77. PubMed ID: 19960244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array.
    Jung SH; Shin SH; Yim SH; Choi HS; Lee SH; Chung YJ
    Exp Mol Med; 2009 Jul; 41(7):462-70. PubMed ID: 19322034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors.
    Terashima K; Yu A; Chow WY; Hsu WC; Chen P; Wong S; Hung YS; Suzuki T; Nishikawa R; Matsutani M; Nakamura H; Ng HK; Allen JC; Aldape KD; Su JM; Adesina AM; Leung HC; Man TK; Lau CC
    Pediatr Blood Cancer; 2014 Apr; 61(4):593-600. PubMed ID: 24249158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.